Severe Exacerbation of Myasthenia Gravis Associated with Checkpoint Inhibitor Immunotherapy

Journal of Neuromuscular Diseases
Dana S CooperRabia Malik

Abstract

Monoclonal antibodies that target either PD-1 or PD-L1 have recently been approved for treatment of advanced non-small cell lung cancer. These antibodies are immune checkpoint inhibitors which have been shown to exacerbate Myasthenia Gravis (MG) and other autoimmune diseases. While effective in preventing tumor cells from evading immune attack, immune checkpoint inhibitors such as nivolumab, an antibody directed against the programmed cell death protein-1 (PD-1) receptor located on T-cells, may also cause immune dysregulation and could cause or potentiate pre-existing autoimmune conditions. We present a patient with latent ocular MG treated with nivolumab for her stage IV non-small cell lung cancer who developed generalized MG and severe myasthenic crisis. Providers must be aware of the risks inherent to these novel therapies since they can have life-threatening effects.

References

Jul 9, 2003·The Journal of Experimental Medicine·Alan D SalamaSamia J Khoury
Jun 18, 2005·Genome Biology·Mary CollinsBeatriz M Carreno
Dec 30, 2006·Cancer Immunology, Immunotherapy : CII·Christian Blank, Andreas Mackensen
Oct 7, 2008·Oncogene·T J Stewart, S I Abrams
Dec 17, 2009·The Journal of Experimental Medicine·Loise M FranciscoArlene H Sharpe
Dec 21, 2012·Annals of the New York Academy of Sciences·Muthusamy ThiruppathiMatthew N Meriggioli
Jan 30, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E KertyN E Gilhus
Apr 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Douglas B JohnsonJeffrey A Sosman
Dec 24, 2014·Nature Reviews. Immunology·Linh T Nguyen, Pamela S Ohashi
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Dec 26, 2015·Journal of Neurology·Sophie BinksJacqueline Palace
Jan 24, 2016·Muscle & Nerve·Julia Zhu, Yuebing Li
Jun 12, 2016·Muscle & Nerve·Giorgia SciaccaMario Zappia
Jul 16, 2016·Cancer Science·Toshihiro KimuraHironobu Ihn
Aug 21, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cun-Jin ZhangYaping Yan
Jan 23, 2017·Neuromuscular Disorders : NMD·Natalia L GonzalezSaša A Živković

❮ Previous
Next ❯

Citations

Sep 25, 2017·Muscle & Nerve·John S YiKevin C O'Connor
Mar 1, 2018·The Oncologist·Nizar M TannirMichael B Atkins
May 16, 2018·Annals of Clinical and Translational Neurology·Robert WilsonSarosh R Irani
Nov 2, 2019·Expert Opinion on Pharmacotherapy·Carolina BarnettVera Bril
Jun 15, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Laura C KennedyPetros Grivas
Mar 11, 2020·Frontiers in Immunology·Ruksana Huda
Nov 5, 2020·Neurology·Pushpa NarayanaswamiJan Verschuuren
Jan 5, 2021·Journal of the American College of Emergency Physicians Open·Sai-Ching Jim YeungKumar Alagappan
Jan 16, 2021·Clinical Medicine Insights. Oncology·Muhammad JafferSepideh Mokhtari
Nov 12, 2020·Eye and Brain·Caberry W YuJonathan A Micieli
Mar 28, 2021·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K RzeniewiczS Turajlic
Aug 25, 2021·BMJ Case Reports·Behnam HajihossainlouKanishka Chakraborty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.